134 related articles for article (PubMed ID: 3198983)
1. Aminozolamide suspension: the role of the vehicle in a topical carbonic anhydrase inhibitor.
Lewis RA; Schoenwald RD; Barfknecht CF
J Ocul Pharmacol; 1988; 4(3):215-9. PubMed ID: 3198983
[TBL] [Abstract][Full Text] [Related]
2. Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension.
Lewis RA; Schoenwald RD; Barfknecht CF; Phelps CD
Arch Ophthalmol; 1986 Jun; 104(6):842-4. PubMed ID: 3521557
[TBL] [Abstract][Full Text] [Related]
3. Topical carbonic anhydrase inhibitors.
Kass MA
Am J Ophthalmol; 1989 Mar; 107(3):280-2. PubMed ID: 2923154
[No Abstract] [Full Text] [Related]
4. Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.
Lewis RA; Schoenwald RD; Eller MG; Barfknecht CF; Phelps CD
Arch Ophthalmol; 1984 Dec; 102(12):1821-4. PubMed ID: 6548907
[TBL] [Abstract][Full Text] [Related]
5. Ocular disposition of aminozolamide in the rabbit eye.
Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
[TBL] [Abstract][Full Text] [Related]
6. The study of ocular hypotensive effect of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
Lu DW; Chiang CH; Kao KD; Wen LY
J Ocul Pharmacol; 1990; 6(4):271-8. PubMed ID: 2097310
[TBL] [Abstract][Full Text] [Related]
7. Topical carbonic anhydrase inhibitors.
Schoenwald RD; Eller MG; Dixson JA; Barfknecht CF
J Med Chem; 1984 Jun; 27(6):810-2. PubMed ID: 6737424
[TBL] [Abstract][Full Text] [Related]
8. Characterization of arylamine acetyltransferase in the rabbit eye.
Campbell DA; Schoenwald RD; Duffel MW; Barfknecht CF
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2190-200. PubMed ID: 2071333
[TBL] [Abstract][Full Text] [Related]
9. Biopharmaceutical explanation for the topical activity of 6-hydroxyethoxy-2-benzothiazolesulfonamide in the rabbit eye.
Lee DY; Schoenwald RD; Barfknecht CF
J Ocul Pharmacol; 1992; 8(3):247-65. PubMed ID: 1453087
[TBL] [Abstract][Full Text] [Related]
10. 6-amino-2-benzothiazole-sulfonamide. The effect of a topical carbonic anhydrase inhibitor on aqueous humor formation in the normal human eye.
Kalina PH; Shetlar DJ; Lewis RA; Kullerstrand LJ; Brubaker RF
Ophthalmology; 1988 Jun; 95(6):772-7. PubMed ID: 3211479
[TBL] [Abstract][Full Text] [Related]
11. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
12. Ocular distribution studies of the topical carbonic anhydrase inhibitors L-643,799 and L-650,719 and related alkyl prodrugs.
Grove J; Gautheron P; Plazonnet B; Sugrue MF
J Ocul Pharmacol; 1988; 4(4):279-90. PubMed ID: 3246565
[TBL] [Abstract][Full Text] [Related]
13. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
Wilkerson M; Cyrlin M; Lippa EA; Esposito D; Deasy D; Panebianco D; Fazio R; Yablonski M; Shields MB
Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
[TBL] [Abstract][Full Text] [Related]
14. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
Sugrue MF; Mallorga P; Schwam H; Baldwin JJ; Ponticello GS
Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
[TBL] [Abstract][Full Text] [Related]
15. Topical carbonic anhydrase inhibitors. III: Optimization model for corneal penetration of ethoxzolamide analogues.
Eller MG; Schoenwald RD; Dixson JA; Segarra T; Barfknecht CF
J Pharm Sci; 1985 Feb; 74(2):155-60. PubMed ID: 3989684
[TBL] [Abstract][Full Text] [Related]
16. Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
Kao KD; Lu DW; Chiang CH; Huang HS
J Ocul Pharmacol; 1990; 6(4):313-20. PubMed ID: 2097315
[TBL] [Abstract][Full Text] [Related]
17. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Schmitt C; Viader MP; Conquet P; Smith RL; Share NN; Stone CA
J Pharmacol Exp Ther; 1985 Feb; 232(2):534-40. PubMed ID: 3838190
[TBL] [Abstract][Full Text] [Related]
18. Topically active carbonic anhydrase inhibitors. 1. O-acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide.
Woltersdorf OW; Schwam H; Bicking JB; Brown SL; deSolms SJ; Fishman DR; Graham SL; Gautheron PD; Hoffman JM; Larson RD
J Med Chem; 1989 Nov; 32(11):2486-92. PubMed ID: 2810337
[TBL] [Abstract][Full Text] [Related]
19. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Schwam H; Baldwin JJ; Christy ME; Ponticello GS
J Ocul Pharmacol; 1990; 6(1):9-22. PubMed ID: 2362161
[TBL] [Abstract][Full Text] [Related]
20. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
